info

Yes No
Please Note
We brought you to this page based on your search query. If this isn't what you are looking for, you can continue to Search Results for ""
The maximum number of items you can export is 3,000. Please reduce your list by using the filtering tool to the left.
Close
Close
Please Log In to access this content

Registered User

Please log in for full access to your permissions. Password is case sensitive.
User Name:
Password:
Automatically log me in when I return
Forgot your Username or Password?
Or Log In using:

Not Registered Yet?

Register now to get FREE access to:

Issuer Ratings.

Ratings on over 170,000 corporate, government and structured finance securities.

Events Calendar.

Information about training seminars, briefings, and teleconferences.

Watchlists.

Listings of issuers under review for rating changes.

Rating Methodologies.

Descriptive frameworks underlying Moody's ratings.

 

Register Now
Chem Rx Corporation
Moody's Org ID:820533549
Market Segment:Corporates
Industry:WHLSL DSTRBTN: HEALTHCARE
Peer Group:Global Distribution and Supply Chain Services
Domicile:UNITED STATES
Please Log In to view this content.
Research Ratings Family Tree Peer Group Market Signals

Issuer Research Industry Research Family Tree Research Methodology
Results  1 - 11 Of  11
Previous  Page  1 Of  1  Next
Filter By:
Date Document Type Title Source
22 Dec 2009 Rating Action
The document has been translated in other languages

Moody's Lowers Chem Rx's CFR to Caa3; Ratings to be Withdrawn
Moody's Investors Service
08 Apr 2009 LGD Assessment
The document has been translated in other languages

Chem Rx Corporation
Moody's Investors Service
08 Apr 2009 Credit Opinion
The document has been translated in other languages

Chem Rx Corporation
Moody's Investors Service
06 Apr 2009 Rating Action
The document has been translated in other languages

Moody's Lowers Chem Rx's CFR to Caa1; Ratings Placed Under Review
Moody's Investors Service
19 Dec 2008 Rating Action
The document has been translated in other languages

Moody's Lowers Chem Rx's CFR to B3; Outlook Remains Negative
Moody's Investors Service
21 Oct 2008 Rating Action
The document has been translated in other languages

Moody's Downgrades Chem Rx's Liquidity Rating to SGL-4
Moody's Investors Service
18 Apr 2008 Announcement
The document has been translated in other languages

Moody's Revises Chem Rx's Ratings Outlook to Negative
Moody's Investors Service
18 Apr 2008 LGD Assessment
The document has been translated in other languages

Chem Rx Corporation
Moody's Investors Service
02 Apr 2008 Issuer Comment
The document has been translated in other languages

Moody's comments on Chem Rx filing delay
Moody's Investors Service
11 Oct 2007 LGD Assessment
The document has been translated in other languages

Chem Rx Corporation
Moody's Investors Service
19 Sep 2007 Rating Action
The document has been translated in other languages

Moody's assigns B2 CFR to Chem Rx; stable ratings outlook
Moody's Investors Service
Results  1 - 11 Of  11
Previous  Page  1 Of  1  Next

6The rating history for this credit rating accurately reflects the current status of the (sf) indicator but, due to technical limitations, does not accurately reflect the (sf) indicator history. Please visit the Research tab to view the press release(s) announcing when the (sf) indicator was added or removed.

For credit ratings that are derived exclusively from an existing credit rating of a program, series, category/class of debt, support provider or primary rated entity, or that replace a previously assigned provisional rating at the same rating level, Moody’s publishes a rating announcement on that series, category/class of debt or program as a whole, on the support provider or primary rated entity, or on the provisional rating, but often does not publish a specific rating announcement on each subsequent bond or note for which the credit rating is derived from the existing credit rating. Rating announcements are usually press releases classified as Rating Actions on www.moodys.com. Please refer to the Research tab on the issuer/entity page for the rating announcement.

Moody's Integrity Hotline

Via the Internet: 
https://Moodys.ethicspoint.com
By telephone from the United States: 
Dial 1-866-330-MDYS (1-866-330-6397)
By telephone from outside the United States:  

Dial the AT&T Direct Dial Access® code for your location.

Then, at the prompt, dial 866-330-MDYS (866-330-6397).
HomeResearch & RatingsProducts & SolutionsNews & EventsCareers
Help & SupportContact UsSubmit a Complaint
Terms of UsePrivacy PolicyProprietary Rights
© 2018 Moody's Investors Service, Inc., Moody’s Analytics, Inc. and/or their affiliates and licensors. All rights reserved.